Between 2019 and 2022, the Saudi Food and Drug Authority (SFDA) extensively updated the medical device regulations in Saudi Arabia. In particular, the requirements for medical device marketing authorisation (MDMA) had evolved to cope with EU Medical Device Regulations (MDR) updates.
The continuous development of medical device registration procedures increased the complexity of the process. To market in Saudi, all medical devices, including low-risk classes and in vitro diagnostics(IVDs), must be MDMA registered through the technical file application (TFA) route.
In this article, we will clarify the SFDA medical device registration requirements and define the differences in the classification of medical devices according to EU regulations.
For other types of product registration, refer to the SFDA registration post.
The SFDA regulates medical device products in Saudi Arabia to ensure their safety, efficacy, and quality. Medical device manufacturers must acquire SFDA approval (MDMA) before marketing their products. Post-approval, they are responsible for safety reporting and other life cycle management, such as MDMA update, renewal, and submission of the Unique Device Identification (UDI).
Here is a summary of the registration procedures for medical devices:
Since January 2022, all medical devices, equipment, supplies, software/apps, and IVD products must have SFDA approval through the MDMA registration route called TFA (MDMA2). This route has resulted from the SFDA’s continuous regulations updates influenced by the EU MDR and IVDR. This route requires presenting the technical documentation in a clear, searchable, and organised manner.
Therefore, the registration requirements became more stringent, with many conditions to meet and studies to provide, such as clinical evaluation reports (CER), biocompatibility test reports, and the need to conduct a post-market clinical follow-up (PMCF) study in Saudi Arabia.
Although the TFA file is similar to the CE mark file, having a CE certificate to receive SFDA approval is not mandatory. However, without a CE mark, the product file will undergo a rigorous assessment requiring an experienced regulatory professional.
The SFDA considered approvals from the countries of the GHTF members, such as the European Union, the United States, Canada, Australia, and Japan. This was an easy route to follow without deep technical inquiries. However, by the end of 2021, the SFDA had cancelled this GHTF route.
Companies used to register Non-sterile, non-measuring, Low-Risk Medical Devices through the Medical Device National Registry (MDNR), also known as “Medical Devices Listing,” which is exempt from MDMA and AR. However, in September 2022, the SFDA cancelled the MDNR procedure. Therefore, all devices must have a technical file for MDMA with an appointed (AR) in Saudi Arabia.
The SFDA also regulates medical device companies in the Saudi market and enforces special requirements on international companies. Below are the requirements for both types:
The SFDA licenses local medical device companies such as importers, distributors, warehouses, and manufacturers. This license is called the Medical Device Establishment License (MDEL). All previous types of companies must implement a quality management system (QMS) and have an ISO 13485 certificate.
International legal manufacturers must appoint an authorised representative (AR) company in Saudi Arabia; this is the first step in enabling communication with the SFDA. The AR’s primary responsibility is product compliance in pre- and post-marketing activities. The AR will maintain registration status, facilitate shipments, monitor safety, report cases, and represent the company in the Saudi market for regulatory or governmental matters.
The applicant is responsible for classifying the product according to SFDA rules and creating the related files in the technical file. Generally, the SFDA medical device classification will follow the same class in the reference EU regulation (CE certificate). However, SFDA will not consider other countries’ regulations; a low-risk medical device in a country could be high risk in Saudi Arabia, and vice versa.
SFDA medical device classification is either Class A, B, C, or D. This is according to their risk class. The class is necessary to determine the registration procedure and its requirements, as discussed in the table below:
SFDA Classification | Risk Class | MDR Classification Rule |
Class A | Low | I |
Class A – Sterile | Low-medium | Is |
Class A – Measuring function | Low-medium | Im |
Class A – Reusable surgical instruments | Low-medium | Ir |
Class B | Low-medium | IIa |
Class C | Medium-high | IIb |
Class D | High | III |
The applicant is responsible for the classification of their device in Saudi according to the following Risk Classification Rules for Medical Devices:
Identical devices could be classified differently according to the targeted part of the body. Therefore, the intended use is crucial in determining the correct classification. The intended use reference is in the following:
Concerning in vitro diagnostics, the SFDA is also adopting the European medical device regulation IVDR:
SFDA IVD Classification | Risk Class | Classification Rule |
Class A | Low individual risk and low public health risk | A |
Class B | Moderate individual risk and/or low public health risk | B |
Class C | High individual risk and/or moderate public health risk | C |
Class D | High individual risk and high public health risk | D |
The applicant is responsible for determining the class of the IVD by:
After appointing an authorised representative, the applicant can submit the product registration application. The following summarises the requirements, which vary according to the product type and class. Here are the high-level sections of the registration file:
Time needed: 90 days
We can summarise the medical device registration (MDMA) approval process in the following few steps:
Manufacturers must appoint an AR to represent their company in Saudi Arabia. Read about Independent AR.
Companies must establish a thorough gap analysis on the registration file against the SFDA requirements. Identifying the gaps is essential to determining the must-have studies, reports, or post-approval commitments, such as PMCF in Saudi Arabia. It also protects against rejection, which costs time and government fees.
The applicant submits the technical file to the SFDA. Contact us to request a registration service.
This step doesn’t include an application review by the SFDA; it is a quick scan, so the SFDA quickly rejects files submitted by non-professionals.
If the file passes the initial validation, the applicant will receive an invoice for the SFDA fees. This invoice must be paid before the start of the assessment and is not refundable.
The assessors will review the product file and send back their inquiries in multiple. The assessors do not detail the nature of compliance; they will point out the non-compliant section.
When granted by SFDA, the license owner (the legal manufacturer) can ship the goods to the Saudi market.
Grouping multiple devices in the same application is permissible; the applicant may bundle up to 50 items in one MDMA application. However, products must meet several conditions, such as having the same risk class and intended use.
The assessment timelines vary according to many factors, such as risk class, complexity of the product, number of bundled products, and the completeness of the file. Non-identified gaps before the submission will risk delaying the approval. The entire timelines for the registration project include:
The MDMA application fees vary according to the medical device Class and the number of products in the application. For the updated fees, please refer to our updated SFDA Fees post.
MDMA’s default validity is three years. Companies can submit the renewal application three months (90 days) before the license expires. Regarding the update of an approved device, There are minor and major update types; both differ in fees and timelines. Applicants can submit them at any time during the license’s validity.
SFDA will issue an MDMA certificate in both Arabic and English containing the following:
Importing medical devices requires valid MDMA. However, the SFDA may exempt some medical devices from registration and only require them to issue a medical device importing license (MDIL). For example:
Whether your company is new to or already active in the Saudi market, PharmaKnowl will help you comply with the SFDA. We are an SFDA-licensed consulting company that provides regulatory and authorised representative services in Saudi Arabia for international companies worldwide.
Contact us for more information.
We support global Pharma and Medical Devices companies in the Saudi market with professional regulatory services. Send us your request to kick off your SFDA project.
Start Here